Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma

Fig. 6

Expression of MAD2L1 and CCNB2 in RMS tissues and cells. a IHC analysis of MAD2L1 demonstrates strong nuclear expression in patients with RMS. Negative control, ERMS, ARMS, PRMS (all ×200). b IHC analysis of CCNB2 demonstrates cytoplasm or nuclear expression in patients with RMS. Negative control, ERMS, ARMS, PRMS (all ×200). c Western blot shows the expression of MAD2L1 and CCNB2 in normal skeletal muscle cells (HSKMC) and RMS cell lines (RD, PLA-802, RH30)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us